Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Applying a special DNA plasmid to the skin can make it thicker and stronger.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Injectable skin boosters effectively rejuvenate aging skin by improving hydration and elasticity.

These three weeds have important medicinal properties and need more research for potential pharmaceutical use.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain genetic variants in keratins increase the risk of tooth decay.

Looking at skin can help find and treat serious diseases early.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Hes1 protein is important for hair growth and regeneration, and could be a potential treatment for hair loss.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.

Targeting EGFR may help reduce hair loss from chemotherapy.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.